Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/67602
Title: Chemical Constituents of Anneslea fragrans and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line
Authors: Ashraf M. Omar
Dya Fita Dibwe
Ahmed M. Tawila
Sijia Sun
Ampai Phrutivorapongkul
Suresh Awale
Authors: Ashraf M. Omar
Dya Fita Dibwe
Ahmed M. Tawila
Sijia Sun
Ampai Phrutivorapongkul
Suresh Awale
Keywords: Biochemistry, Genetics and Molecular Biology;Chemistry;Medicine;Pharmacology, Toxicology and Pharmaceutics
Issue Date: 22-Nov-2019
Abstract: © 2019 American Chemical Society and American Society of Pharmacognosy. An ethanolic extract of Anneslea fragrans leaves showed potent preferential cytotoxicity against PANC-1 human pancreatic cancer cells under a nutrient-deprived condition, with a PC50 value of 9.6 μg/mL. Phytochemical investigation of this active extract led to the isolation of two new secondary metabolites, fragranones A (1) and B (2), along with 15 previously reported compounds. The structure elucidation of the new compounds was achieved by HRFABMS, acid hydrolysis, NMR, and ECD spectroscopic analysis. Fragranone A (1) is the first example of a rare natural product bearing an acetonide glucose moiety. Fragranone B (2) is representative of a rare class of natural products with a threonolactone unit linked to a chalcone through an ether linkage. The isolated compounds exhibited antiausterity activity against PANC-1 cells under nutrient-deprived conditions, and betulin (14) was found to be the most potent compound tested, with a PC50 value of 8.4 μM. In addition, fragranone A (1) was found to suppress PANC-1 cancer cell migration in real time.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074785868&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/67602
ISSN: 15206025
01633864
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.